Loading clinical trials...
Loading clinical trials...
An Open-label, Randomized, Fasting, Single, Oral Administration, Group 2, Stage 2, Cross-over Bioequivalence Study of AG2202 in Healthy Volunteers
Conditions
Interventions
AG2202T
AG2202R
Start Date
August 1, 2024
Primary Completion Date
September 1, 2024
Completion Date
September 1, 2024
Last Updated
August 14, 2024
NCT06969963
NCT06924190
NCT06600282
NCT06579053
NCT05436769
NCT04229602
Lead Sponsor
Ahn-Gook Pharmaceuticals Co.,Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions